Acquired punctate palmoplantar keratoderma following Programmed cell death protein 1 inhibitor therapy. [PDF]
Sarkar N, Markidan J, Gibbs M, Helm K.
europepmc +1 more source
Dysregulated cholesterol metabolism in genodermatoses: implications for systemic disease and therapeutic strategies. [PDF]
Xiao Z, Kang Y, Li R, Tan Y.
europepmc +1 more source
Familial CARD14-associated papulosquamous eruption with a novel mutation successfully treated with secukinumab. [PDF]
Ren J, Tan G, Shi Z.
europepmc +1 more source
Symmetric hyperkeratotic plaques of palms and soles: a case of palmoplantar psoriasis. [PDF]
Choudhary KS, Wanjari AS.
europepmc +1 more source
Atypical presentation of DRESS/DiHS mimicking an acquired ichthyosis: A case report of bortezomib-induced severe erythroderma in multiple myeloma. [PDF]
Lu C +5 more
europepmc +1 more source
Identification of a KRT9 gene variant and preimplantation genetic diagnosis in a Chinese family with KRT9-palmoplantar epidermal differentiation disorder. [PDF]
Lin D, Lin N, Zhou Y, Li Q, Ma Y.
europepmc +1 more source
Papillon-Lefèvre Syndrome: Case Report of Two Sisters. [PDF]
El-Missioui A, Benkarroum FZ, Ramdi H.
europepmc +1 more source
Palmoplantar keratoderma in a middle-aged male. [PDF]
Siriwardene M, Isaacs F.
europepmc +1 more source
Capecitabine was developed as a prodrug of 5-fluorouracil (FU), with the goal of improving tolerability and intratumour drug concentrations through tumour-specific conversion to the active drug against numerous types of neoplasms. The most frequent adverse cutaneous reaction associated with capecitabine is hand foot syndrome (HFS), presented with ...
J E, Do, Y C, Kim
openaire +3 more sources

